An observational study in Acquired Brain Injury and Consciousness, Level Altered, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-03-09.
Sponsored by Rigshospitalet, Denmark · Observational
Among 20 studies in Brain Injuries by Rigshospitalet, Denmark — 5 open to participants now, 7 under way, none of them phase 3. Brain Injuries · Rigshospitalet, Denmark.
Among the 20 studies in Brain Injuries by Rigshospitalet, Denmark, this one is the 10th largest by enrollment of the 13 observational ones that give a count, is one of 4 that started in 2017, is one of 14 observational ones, and was the 5th registered.
946 studies on the registry are indexed under Brain Injuries; 235 are open to participants now.
Browse Brain Injuries studies →5 of the 20 studies in Brain Injuries by Rigshospitalet, Denmark are open now, in 1 country. Recruiting first, the newest first:
Rigshospitalet, Denmark · Sites in Denmark
Rigshospitalet, Denmark · Sites in Denmark
Rigshospitalet, Denmark · Sites in Denmark
Rigshospitalet, Denmark · Sites in Denmark
Rigshospitalet, Denmark · Sites in Denmark
By country, each count listing its studies:
Of the 152 Brain Injuries studies recruiting now, 75 (49%) set no upper age limit and 55 (36%) stop at 75 or younger; 39 take children under 18; 23 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 4 started in 2017.
This study's enrollment of 6 is below the median of 100 across 302 observational studies indexed under Brain Injuries.
Median enrollment 98 across the 6 interventional studies, 100 across the 13 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Rigshospitalet, Denmark is the lead sponsor of 1,007 studies on the registry; 175 are open to participants now.
2 of the studies in Brain Injuries by Rigshospitalet, Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07380477Rigshospitalet, DenmarkVentricuLostomy AssoCiaTed InfeCtions (LACTIC): Focus on CSF Lactate and Sampling Site | 2027-01-15 |
| NCT07590726Rigshospitalet, DenmarkPIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors | 2027-04-01 |
Among the 20 studies in Brain Injuries by Rigshospitalet, Denmark, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to explore autonomic cardiovascular regulation, through measures of heart rate variability (HRV), during different passive and active activities in patients with severe acquired brain injury and a low conscious state. Data from active rehabilitation will be compared with passive periods of rest as well as nightly variance during a continuous 5-day period.
Background Severe acquired brain injury is usually associated with permanent disabilities in motor skills and cognitive functions that inhibit patients level of functioning, communication, participation in social activities and ability to work [Faul et al 2015, McLafferty et al 2016]. Patients with severe brain injury often have reduced level of consciousness in the early stages after the incident. Studies have shown that the autonomic nervous system can be affected in these patients, shown by analysis of the heart rate variability in the low frequency domain [Riberholt et al 2016, Vistisen et al 2014]. Signals from motor- and sensory cortex can influence sympathetic and parasympathetic activity and thus be a part of the cardiovascular adaptation during function [Sequeira et al 2000]. Aerobic exercise has been demonstrated to be effective regarding to autonomic cardiovascular regulation among healthy workers [Hallman et al 2017].
One method to assess sympathetic- and parasympathetic activity of the autonomous nervous system, as well as baroreflex sensitivity, is through the analysis of heart rate variability (HRV) [van de Vooren et al 2007]. A study of traumatic brain injured patients admitted to a neurocritical intensive care unit reveals that reduced HRV and baroreflex sensitivity within the first week of admission is associated with a poor neurological outcome at 1 year post-injury [Henden et al 2014]. Patients with severe acquired brain injury and low state of consciousness has demonstrated vastly reduced HRV and baroreflex sensitivity 40 days post injury during rest and head-up tilt[Riberholt et al 2016, Vistisen et al 2014].
Rehabilitation of patients with severe acquired brain injury and low state of consciousness is multimodal. Physical stimulation of the cardiovascular system can be exercised through an array of interventions such as mobilization, standing using a tilt-table, bed-biking, robot-assisted walking or other methods. To the authors' knowledge, no studies have been published researching the association between physical stimulation and HRV in patients with severe acquired brain injury in the subacute phase.
Hypotheses
Methods This is a prospective observational study. Patients are recruited from the Department of Neurorehabilitation/TBI Unit, Rigshospitalet, Denmark. This study will include patients above 18 years of age with severe acquired brain injury admitted for highly specialized neurorehabilitation. Patients must have a low level of consciousness defined as either vegetative or minimally conscious state. Five days of continuous heart rate monitorization at a sample rate of 256 Hz will start approximately 40 days after the initial injury using the ePatch® system. This study has been approved by the local ethics committee in the capital region of Denmark and oblige to the principles of the Helsinki Declaration. All data will be depersonalized and the Danish data protection agency has approved this study.
Treatment Participants will receive usual care, as practiced at the study location, regarding both medical care and rehabilitation efforts. There is no experimental intervention nor added or reduced treatment associated with this study.
Measurements Five days of continuous electrocardiography (ECG) will be recorded with ePatch (BioTelemetry Technology ApS, Denmark). The apparatus has a build-in inclinometer, accelerometer and the opportunity to mark the initiation of an event; in this case physical exercise, and is able to monitor heart rate continuously for five days at a sample rate of 256 Hz. The Epatch is attached to the patient's skin, over their sternum, using an adhesive patch. It can withstand most daily activities and is splash resistant. If medical imaging is necessary the ePatch will be removed and replaced afterwards.
Statistical analysis For statistical analysis of data comparing mean HRV of (T-exercise) with (T-rest) and (T-night) with (T-day) the paired t-test or equivalent non-parametric method will be utilized. A mixed effects model repeated measure analysis or equivalent non-parametric method (restricted maximum likelihood) will be performed for comparative analysis of variation from the 5 days of data collection.
Foreseeing the need in some cases to remove the ePatch, for various reasons, within the span of the 5 days of data collection, data will be included if events from 3 days of measurements can be extracted.
Data extracted from the participants medical record will be used to comprise a table of demographic characteristics that will include data on: age, sex, diagnose, body mass index (BMI), Glasgow Coma Score (GCS) at admittance, days removed from injury, level of functioning as measured with Early Functional Abilities scale (EFA) as well as level of consciousness as measured with Coma Recovery Scale - Revised (CRS-R). Likewise, data of participants medicinal intake during the study period will be retrieved from their medical record.
Ethical considerations As participants receive usual care no direct benefits are associated with this study.
Potential scientific benefits Researching autonomic cardiovascular regulation through HRV in patients with severe acquired brain injury is a relatively novel area. This exploratory study can help provide provisional information and thus generate further hypotheses for studies generating evidence of higher quality.
Harms The ePatch is designed for home-monitoring with an emphasis on ensuring minimum discomfort during use and is CE certified for clinical usage. During use or at removal, some individuals may experience slight skin-irritation under the adhesive patch that holds the ePatch in place. We assess the potential risks of participating in this study to be minimal.
Reporting of harms All adverse events related to participation in this study will be continuously monitored during the study. Besides notifying the local ethics committee, a list of encountered adverse events will be presented at publication.
Stopping guideline If 2 patients present allergic skin-reactions to the ePatch or adhesive patch during data collection the study will pause and consult with the manufacturers. If further 2 patients, after consultation with the manufacturers, present allergic skin-reactions the study will shut down.
Financial conditions This study is part of a thesis initiated by Jon Damsager Lauesen, Christian Gunge Riberholt and Karen Søgaard. Patients included in this study will not be financially compensated.
Adult patients admitted at Department of Neurorehabilitation/TBI Unit, Rigshospitalet, Denmark, with a low conscious state (vegetative or minimally conscious state) 40 days removed from injury.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Low frequency (LF) spectral analysis
LF (0.05-0.15 Hz) during activity (T-exercise), rest (T-rest) and sleep (T-night)
Time frame: 5 days of continuous measurements
High frequency (HF) spectral analysis
HF (0.15-0.35 Hz) during activity (T-exercise), rest (T-rest) and sleep (T-night)
Time frame: 5 days of continuous measurements
LF/HF ratio
The ratio between the power of LF and HF frequency bands during activity (T-exercise), rest (T-rest) and sleep (T-night)
Time frame: 5 days of continuous measurements
SDRR
Standard deviation of the RR-intervals during activity (T-exercise), rest (T-rest) and sleep (T-night)
Time frame: 5 days of continuous measurements
Ran from Sep 2017 to primary completion in Dec 2018, 15 months.
Of 143 non-industry observational studies under Brain Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 73. This study's 15 months is below that.
Counting every sponsor, half of 148 studies reached it within 31 months; a quarter within 16 and three quarters within 73.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.